351 results on '"Piaggio, Eliane"'
Search Results
2. Acyl-coenzyme a binding protein (ACBP) - a risk factor for cancer diagnosis and an inhibitor of immunosurveillance
3. Specialized Tfh cell subsets driving type-1 and type-2 humoral responses in lymphoid tissue
4. CD74 supports accumulation and function of regulatory T cells in tumors
5. Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial
6. Author Correction: CBX3 antagonizes IFNγ/STAT1/PD-L1 axis to modulate colon inflammation and CRC chemosensitivity
7. Breast cancer remotely imposes a myeloid bias on haematopoietic stem cells by reprogramming the bone marrow niche
8. Assessing personalized responses to anti-PD-1 treatment using patient-derived lung tumor-on-chip
9. Imaging and multi-omics datasets converge to define different neural progenitor origins for ATRT-SHH subgroups
10. Author Correction: CD8+T cell responsiveness to anti-PD-1 is epigenetically regulated by Suv39h1 in melanomas
11. Autoimmunity affecting the biliary tract fuels the immunosurveillance of cholangiocarcinoma
12. Phase Ib/II trial of tipapkinogene sovacivec, a therapeutic human papillomavirus16-vaccine, in combination with avelumab in patients with advanced human papillomavirus16-positive cancers
13. CD8+T cell responsiveness to anti-PD-1 is epigenetically regulated by Suv39h1 in melanomas
14. Transcriptional and Functional Analysis of CD1c+ Human Dendritic Cells Identifies a CD163+ Subset Priming CD8+CD103+ T Cells
15. CTIM-24. REPEATED PERIPHERAL INFUSIONS OF ANTI-EGFRVIII CAR T CELLS IN COMBINATION WITH PEMBROLIZUMAB REMODELS THE TUMOR MICROENVIRONMENT IN DE NOVO GLIOBLASTOMA
16. Prognostic value of intratumoral Fusobacterium nucleatum and association with immune-related gene expression in oral squamous cell carcinoma patients
17. Peptide–TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens
18. Mechanisms of Resistance to Immune Checkpoint Antibodies
19. Interleukin-17 signaling influences CD8 + T cell immunity and tumor progression according to the IL-17 receptor subunit expression pattern in cancer cells
20. Treg-targeted IL-2/anti-IL-2 complex controls graft-versus-host disease and supports anti-tumor effect in allogeneic hematopoietic stem cell transplantation
21. CD39 + conventional CD4 + T cells with exhaustion traits and cytotoxic potential infiltrate tumors and expand upon CTLA-4 blockade
22. Humanized Mice for the Study of Immuno-Oncology
23. Ex vivoquantification of anti-tumor T-cell activity upon anti-PD-1 treatment in patient-derived lung tumor-on-chip
24. Tumor invasion in draining lymph nodes is associated with Treg accumulation in breast cancer patients
25. Efficient oral vaccination by bioengineering virus-like particles with protozoan surface proteins
26. TRANSIENT ANTIBODY TARGETING OF CD45RC TO PREVENT THE DEVELOPMENT OF ACUTE GRAFT VERSUS HOST DISEASES
27. In Vivo Analysis of Human Immune Responses in Immunodeficient Rats
28. Supplementary figures from IL2/Anti-IL2 Complex Combined with CTLA-4, But Not PD-1, Blockade Rescues Antitumor NK Cell Function by Regulatory T-cell Modulation
29. Data from IL2/Anti-IL2 Complex Combined with CTLA-4, But Not PD-1, Blockade Rescues Antitumor NK Cell Function by Regulatory T-cell Modulation
30. Supplementary Figure 2 from CD16+NKG2Ahigh Natural Killer Cells Infiltrate Breast Cancer–Draining Lymph Nodes
31. Supplementary Figure 3 from CD16+NKG2Ahigh Natural Killer Cells Infiltrate Breast Cancer–Draining Lymph Nodes
32. Supplementary Figure 5 from CD16+NKG2Ahigh Natural Killer Cells Infiltrate Breast Cancer–Draining Lymph Nodes
33. Data from CD16+NKG2Ahigh Natural Killer Cells Infiltrate Breast Cancer–Draining Lymph Nodes
34. Supplementary Figure 4 from CD16+NKG2Ahigh Natural Killer Cells Infiltrate Breast Cancer–Draining Lymph Nodes
35. Supplementary Table 1 from CD16+NKG2Ahigh Natural Killer Cells Infiltrate Breast Cancer–Draining Lymph Nodes
36. CD74 supports Treg accumulation and function in tumors
37. Supplementary Figure 1 from CD16+NKG2Ahigh Natural Killer Cells Infiltrate Breast Cancer–Draining Lymph Nodes
38. Supplementary Table 2 from CD16+NKG2Ahigh Natural Killer Cells Infiltrate Breast Cancer–Draining Lymph Nodes
39. Supplementary Tables S1, S2 and S3. from CD39 Expression Defines Cell Exhaustion in Tumor-Infiltrating CD8+ T Cells
40. Supplementary Legends from CD39 Expression Defines Cell Exhaustion in Tumor-Infiltrating CD8+ T Cells
41. Supplementary Figures S1 through S7 from CD39 Expression Defines Cell Exhaustion in Tumor-Infiltrating CD8+ T Cells
42. CD39+conventional CD4+T cells with exhaustion traits and cytotoxic potential infiltrate tumors and expand upon CTLA-4 blockade
43. Heparan sulfates targeting increases MHC class I- and MHC class II-restricted antigen presentation and CD8+ T-cell response
44. Selective control of transposable element expression during T cell exhaustion and anti–PD-1 treatment.
45. Selective STING stimulation in dendritic cells primes antitumor T cell responses
46. Immunoendocrine dysbalance during uncontrolled T. cruzi infection is associated with the acquisition of a Th-1-like phenotype by Foxp3+ T cells
47. The HP1γ epigenetic silencer dampens IFN-γ response at the gut epithelial barrier
48. Breast cancer remotely imposes a myeloid bias on hematopoietic stem cells by reprogramming the bone marrow niche.
49. Interleukin-17 signaling influences CD8+T cell immunity and tumor progression according to the IL-17 receptor subunit expression pattern in cancer cells
50. Mechanisms of Resistance to Immune Checkpoint Antibodies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.